Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration

    Access Status
    Fulltext not available
    Authors
    Mamo, J.
    Lam, Virginie
    Al-Salami, Hani
    Brook, E.
    Mooranian, A.
    Nesbit, M.
    Graneri, L.
    D'Alonzo, Z.
    Fimognari, N.
    Stephenson, A.
    Takechi, Ryu
    Date
    2018
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Mamo, J. and Lam, V. and Al-Salami, H. and Brook, E. and Mooranian, A. and Nesbit, M. and Graneri, L. et al. 2018. Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration. Therapeutic Delivery. 9 (10): pp. 703-709.
    Source Title
    Therapeutic Delivery
    DOI
    10.4155/tde-2018-0033
    ISSN
    2041-5990
    School
    School of Public Health
    URI
    http://hdl.handle.net/20.500.11937/71806
    Collection
    • Curtin Research Publications
    Abstract

    © 2018 2018 Newlands Press. Aim: To enhance the bioavailability and brain uptake of probucol and examine whether it attenuates neuroinflammation and neurodegeneration by utilizing a sodium alginate nanoencapsulation technique. Materials & methods: Wild-type mice were given either low-fat standard chow, high-fat (HF) diet to induce neuroinflammation and neurodegeneration, HF diet supplemented with nanocapsuled probucol at a concentration of 0.1% (w/w), HF diet supplemented with noncapsulated probucol at the same concentration of 0.1%, or HF diet supplemented with noncapsulated probucol at higher concentration (1%) for 24 weeks. Results & conclusion: The nanoencapsulation increased the plasma and brain concentration of probucol significantly compared with the mice that was given the same dosage of probucol without capsulation, and significantly suppressed the neuroinflammation and neurodegeneration.

    Related items

    Showing items related by title, author, creator and subject.

    • Probucol prevents blood–brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet
      Mamo, John; Lam, Virginie; Brook, E.; Mooranian, A.; Al-Salami, Hani; Fimognari, N.; Nesbit, M.; Takechi, Ryu (2018)
      © The Author(s) 2018. An emerging body of evidence consistently suggests that compromised blood–brain barrier integrity may be causally associated with cognitive decline induced by type-2 diabetes. Our previous studies ...
    • Nutritional and pharmacological regulation of cerebral capillary function
      Pallebage-Gamarallage, Menuka Madhavi Somapala (2012)
      Alzheimer’s disease (AD) is the most common cause of dementia pathologically characterised by neurovascular inflammation, extracellular proteinaceous deposits enriched in amyloid-β (Aβ) and formation of neurofibrillar ...
    • An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques
      Mooranian, Armin ; Zamani, Nassim; Takechi, Ryu ; Luna, Giuseppe; Mikov, M.; Goločorbin-Kon, S.; Elnashar, Magdy ; Arfuso, Frank; Al-Salami, Hani (2019)
      © 2019 Mooranian et al. Type 2 diabetes (T2D) is characterised by β-cell damage and hyperglycaemia. The lipophilic drug, probucol, has shown significant β-cell protective and potential antidiabetic effects, which were ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.